← Back to feed

ECO Animal Health Group

EAH · AIM · Health Care · mcap £65m today

All announcements

All RNS · 27 Key events · 19

17 Sep 26

USDA-CVB approves ECOVAXXIN® MS field safety data

Milestone advances poultry vaccine towards US marketing authorisation
RNS 9776307 ↗
11 Sep 26

Share Awards to Executive Directors

ECO Animal Health Group plc (AIM: EAH), a leading global animal health company developing and marketing branded veterinary products to improve livestock productivity and welfare, announces that on 9 September 2026, nominal cost conditional share options...
RNS 9767728 ↗
08 Sep 26

Result of AGM
RNS 9761701 ↗
08 Sep 26

Didier Branellec appointed Non-Executive Director

ECO Animal Health Group plc (AIM: EAH), a leading global animal health company developing and marketing branded veterinary products to improve livestock productivity and welfare, announces the appointment of Dr.
RNS 9759861 ↗
19 Aug 26

CEO and CFO Exercise of Options and RPT

CEO and CFO Exercise of Share Options and Director/PDMR Shareholdings
RNS 9730635 ↗
12 Aug 26

Exclusive in-licensing agreement with Vaxinano

Exclusive in-licensing agreement with Vaxinano for sheep vaccine candidate against toxoplasmosis
RNS 9716721 ↗
05 Aug 26

Posting of Annual Report and Notice of AGM
RNS 9706426 ↗
28 Jul 26

Holding(s) in Company
RNS 9690964 ↗
16 Jul 26

Director/PDMR Shareholding: CEO Share Purchase Director buys

ECO Animal Health Group plc (AIM: EAH), a leading global animal health company developing and marketing branded veterinary products to improve livestock productivity and welfare, announces that on 16 July 2026 David Hallas, Chief Executive Officer,...
RNS 9673131 ↗
15 Jul 26

Results for the year ended 31 March 2026

Results for the year ended 31 March 2026
RNS 9668984 ↗
13 Jul 26

Notice of Results
RNS 9664244 ↗
02 Jul 26

EU launch of ECOVAXXIN® MS

ECO Animal Health Group plc (AIM: EAH), a leading global animal health company marketing and developing branded veterinary products to improve livestock productivity and welfare, announces the commercial launch of ECOVAXXIN® MS, its poultry vaccine against...
RNS 9648461 ↗
04 Jun 26

Renewal of revolving credit facility

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that it has renewed its committed revolving credit facility ("RCF")...
RNS 9600714 ↗
14 Apr 26

Appointment of Head of Business Development

Dr Andrew Winder to identify strategic growth opportunities for ECO's R&D pipeline
RNS 9517980 ↗
31 Mar 26

Directorate Change

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that Frank Armstrong has informed the Board of his intention to step...
RNS 9499222 ↗
19 Mar 26

Full Year Trading Update

Continued strong momentum in H2 with improved margins outperforming market expectations
RNS 9481434 ↗
11 Mar 26

ECOVAXXIN® MG favourable USDA safety assessment

Assessment represents a significant milestone towards US marketing authorisation
RNS 9468253 ↗
05 Mar 26

Block Listing Return
RNS 9461076 ↗
26 Feb 26

EU launch plans for ECOVAXXIN® MS

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, provides an update on its commercial launch strategy for ECOVAXXIN® MS, its...
RNS 9447703 ↗
19 Jan 26

Holding(s) in Company
RNS 9366105 ↗
22 Dec 25

ECOVAXXIN® MS EU marketing authorisation granted

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that the European Commission has adopted a decision granting EU...
RNS 9311376 ↗
18 Dec 25

Exercise of Share Options by Director

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that Christopher Wilks, Chief Financial Officer, has exercised 4,309...
RNS 9305027 ↗
04 Dec 25

Director/PDMR Shareholding Director buys

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that on 04 December 2025 David Hallas, Chief Executive Officer,...
RNS 9276538 ↗
01 Dec 25

Results for the six months ended 30 September 2025

Results for the six months ended 30 September 2025
RNS 9265975 ↗
20 Nov 25

Notice of Results
RNS 9246616 ↗
20 Nov 25

Notice of Results
RNS 9245499 ↗
10 Nov 25

EMA Positive Opinion Received for ECOVAXXIN® MS

EMA Positive Opinion Received for ECOVAXXIN® MS poultry vaccine
RNS 9222263 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.